NASDAQ:IRTC - Irhythm Technologies Stock Price, Forecast & News

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Irhythm Technologies Inc (NASDAQ:IRTC) posted its quarterly earnings results on Tuesday, November, 5th. The company reported ($0.74) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.40) by $0.34. The firm had revenue of $55.96 million for the quarter, compared to analysts' expectations of $53.76 million. Irhythm Technologies had a negative return on equity of 67.44% and a negative net margin of 26.45%. The firm's revenue for the quarter was up 46.9% on a year-over-year basis. During the same period last year, the business earned ($0.43) earnings per share. View Irhythm Technologies' Earnings History.

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Irhythm Technologies.

Irhythm Technologies issued an update on its FY 2019 Pre-Market earnings guidance on Monday, December, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $213-214 million, compared to the consensus revenue estimate of $216.89 million.

11 analysts have issued 1-year price targets for Irhythm Technologies' stock. Their forecasts range from $75.00 to $125.00. On average, they expect Irhythm Technologies' share price to reach $103.00 in the next year. This suggests a possible upside of 21.2% from the stock's current price. View Analyst Price Targets for Irhythm Technologies.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Irhythm Technologies.

Media stories about IRTC stock have trended extremely negative recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Irhythm Technologies earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Irhythm Technologies.

Some companies that are related to Irhythm Technologies include ABIOMED (ABMD), Hill-Rom (HRC), Haemonetics (HAE), Penumbra (PEN), Globus Medical (GMED), Integra Lifesciences (IART), NuVasive (NUVA), Tandem Diabetes Care (TNDM), ICU Medical (ICUI), Nevro (NVRO), Cantel Medical (CMD), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP) and Cardiovascular Systems (CSII).

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Alibaba Group (BABA), Twilio (TWLO), Tandem Diabetes Care (TNDM), DexCom (DXCM), NVIDIA (NVDA), Splunk (SPLK), Canopy Growth (CGC), Paycom Software (PAYC), Netflix (NFLX) and Paypal (PYPL).

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Irhythm Technologies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Cerebellum GP LLC (0.01%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Raymond W Scott and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies.

IRTC stock was bought by a variety of institutional investors in the last quarter, including Cerebellum GP LLC. View Insider Buying and Selling for Irhythm Technologies.

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRTC stock can currently be purchased for approximately $84.99.

Irhythm Technologies has a market capitalization of $2.26 billion and generates $147.29 million in revenue each year. The company earns $-48,280,000.00 in net income (profit) each year or ($1.89) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.View Additional Information About Irhythm Technologies.

The official website for Irhythm Technologies is http://www.irhythmtech.com/.

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]